Ignite Creation Date:
2024-05-06 @ 12:42 PM
Last Modification Date:
2024-10-26 @ 1:02 PM
Study NCT ID:
NCT03827161
Status:
COMPLETED
Last Update Posted:
2019-02-01
First Post:
2019-01-30
Brief Title:
Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Study Overview
Official Title:
GLANCE 2 - Glucosamine and Chondroitin GC Effects Study
Status:
COMPLETED
Status Verified Date:
2019-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial studies glucosamine and chondroitin in preventing inflammation in overweight patients Chronic inflammation contributes to cancer formation and biomarkers of inflammation have been associated with cancer risk Glucosamine and chondroitin may prevent inflammation and this trial may help identify the bacteria that help process them in the gut
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2018-02647 | OTHER | CTRP | None |